• Sexual Risks in Prep Users

  NCT03975517

  CompletedObservationalUpdated Dec 19, 2022
• Pre-exposure Prophylaxis: A Miracle Drug or a Moral Hazard

  NCT04325555

  CompletedObservationalUpdated Oct 14, 2020
• Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention

  NCT01751659

  CompletedObservationalUpdated Feb 28, 2017
• Sexual Health Impact of Using Pre-exposure HIV Prophylaxis

  NCT05269199

  CompletedObservationalUpdated May 1, 2023
• PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation

  NCT03253757

  Unknown statusObservationalUpdated Aug 18, 2017
• A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African Women

  NCT05746065

  CompletedObservationalUpdated May 8, 2024

ClinicalTrials.gov ID

NCT03893188

Lead Sponsor

University of ZurichOTHER

Overall Status

Recruiting

Study Type

Observational

Enrollment

3,000Estimated

Last Update Posted

Apr 6, 2023Actual

Start Date

Apr 10, 2019Actual

Primary Completion Date

Mar 2030Estimated

Completion Date

Mar 2030Estimated

Official Title

A Multicenter, Observational Cohort to Study the Characteristics of Individuals Asking for Pre-exposure Prophylaxis (PrEP) and the Incidence of HIV and Other Sexually Transmitted Infections: 'The SwissPrEPared Study'

Brief Summary

Nested within the SwissPrEPared Program, the "SwissPrEPared Study" - a large, multicentric, nation-wide cohort study - aims to longitudinally follow individuals asking for PrEP prescription over a period of 3 years.

Detailed Description

The main aims of the study will be:

1. To obtain epidemiological data on individuals asking for PrEP in Switzerland. We are particularly interested in:

   • Determining the extent of PrEP use in Switzerland;
   • Assessing and monitoring the occurrence of sexually transmitted infections (STIs) in this particular population.

2. To assess sexual health and sexual well-being in individuals asking for PrEP using a questionnaire specifically designed for the SwissPrEPared program.

• HIV Preexposure Prophylaxis

Ages Eligible for Study

Child (0-17)Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

Yes

Eligibility Criteria

Inclusion Criteria:

• Participation in the SwissPrEPared program
• Aged ≥16 years
• HIV negative

Exclusion Criteria:

• Individuals unable to follow program procedures (e.g. language barriers, mental or psychiatric disorders)

Observational Model

Cohort

Time Perspective

Prospective

Lead Sponsor

University of ZurichOTHER

Collaborators

Swiss HIV Cohort StudyNETWORK

Federal Office of Public Health, SwitzerlandOTHER_GOV

Positive Council SwitzerlandUNKNOWN

Cantonal Hospital of St. GallenOTHER

University of BernOTHER

Cantonal Hosptal, BasellandOTHER

University Hospital, GenevaOTHER

University of Lausanne HospitalsOTHER

University Hospital, Basel, SwitzerlandOTHER

C.Bernardini@arud.ch